Form D · Biotechnology
MicroVAX, LLC
Manassas, VA · CIK 0001513387
Offering snapshot reported Apr 14, 2015 · SEC filing
- Reported sold
- $298K Offering amount: $298K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $298K Reported outside-investor minimum
- First sale
- Mar 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2015 | Initial | $297,500 | No comparison | 1 | SEC filing |
| Feb 22, 2011 | Initial | $22,500 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237878
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| 0 | 0 | 0 · CRD 0 |
Source: Form D, filed Apr 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jacob Frank | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Mason Enterprise Center 10900 University Blvd., Ms 1 J2
Manassas, VA, 20110
Manassas, VA, 20110